Sporos Bioventures

📍 Houston, United States🗓 Founded 2020👥 10 employees💰 Last funded Oct 2020
Biotechnology🌐 sporosbio.com
Website LinkedIn
Sporos Bioventures is a private biopharmaceutical company that aims to transform the drug development process by focusing on key mechanisms and targets of disease to accelerate drug discovery research to early clinical stage assets using a centralized infrastructure. Programs are discovered and developed by Sporos portfolio companies or by the internal Sporos biodiscovery group, which focuses on small molecules and antibody therapeutics. The Company identifies novel disease mechanisms and strategically deploys people, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos’ current pipeline is diversified across four entities and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. Sporos provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. Sporos is headquartered in Houston with offices in New York and Boston.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Puerto Rico
1
Frequently asked questions
Who invested in Sporos Bioventures?
Sporos Bioventures has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Sporos Bioventures last raise funding?
The most recent investment in Sporos Bioventures recorded on gritt.io was in October 2020.
When was Sporos Bioventures founded?
Sporos Bioventures was founded in 2020.
What industry is Sporos Bioventures in?
Sporos Bioventures operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Sporos Bioventures based?
Sporos Bioventures is headquartered in Houston, United States.